Results 211 to 220 of about 17,678,305 (305)

Expanding Quantitative Medicines' Reach: Systems and Methods to Enhance R&D Productivity and Decision-Making in the Agentic-Era. [PDF]

Clin Transl Sci
Corrigan BW, Anderson E, Tredennick A, Martinez Lomeli L, Pane MC, Dunlap T, Davis B, Rogers J, Gastonguay MR.   +8 more
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Sex-Specific Predictive Value of Obesity-Related Indicators for Diabetic Kidney Disease in Type 2 Diabetes Mellitus. [PDF]

Diabetes Metab Syndr Obes
Mao J, Gong S, Jin J, Tan Y, Zeng L, Zhou Q, Yu F, Zhou H, Lu H, Gan S.   +9 more
europepmc   +1 more source

Spatial biology in cancer epigenetics

Molecular Oncology, EarlyView.
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley   +1 more source

Designing eligibility and evaluation criteria for antibacterial pull incentives: a comparative review of implemented and emerging initiatives. [PDF]

Lancet Reg Health Eur
Anderson M, O'Neill E, Ljungqvist G, Cherla A, Claessens Z, Schoefs E, Crabb N, Cowell W, Cohn J, Patel D, Mossialos E.   +10 more
europepmc   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

Inner beauty supplement label information cues, consumer trust, and purchase intentions: cross-sectional evidence from South Korean consumers. [PDF]

Front Psychol
Park E, Kwon KH.
europepmc   +1 more source

ADP‐ribosylation: An emerging regulator of the epigenome

Molecular Oncology, EarlyView.
ADP‐ribosylation has emerged as a dynamic epigenetic signaling mechanism that modifies histones and chromatin‐associated proteins. Through coordinated PARylation and MARylation, it integrates with other histone modifications to regulate chromatin structure, transcription factor activity, and gene expression, influencing genome function and disease ...
Cristel V. Camacho, Chenqian Liu, W. Lee Kraus   +2 more
wiley   +1 more source

Capturing Heterogeneous Time-Variation in Covariate Effects in Non-Proportional Hazard Regression Models. [PDF]

Biom J
Hagemann N, Kneib T, Möllenhoff K.
europepmc   +1 more source